SBC

SBC Medical Group Holdings Incorporated · NASDAQ · Industrials · USD · 10-K for 2025, filed 2026-03-27

Figures on this page computed 2026-11-08 12:57 UTC

Last close

5.32USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-27

10.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
30.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
29.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
13.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
0.21Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

99.7

2022-12-31 to 2025-12-31100 at the start99.7

Sales: 100.00 on 2022-12-31 to 99.68 on 2025-12-31, down 0%.

Profit

807

2022-12-31 to 2025-12-31100 at the start807

Profit: 100.00 on 2022-12-31 to 807.37 on 2025-12-31, up 707%.

Shares in issue

684

2022-12-31 to 2025-12-31100 at the start684

Shares in issue: 100.00 on 2022-12-31 to 683.61 on 2025-12-31, up 584%.

Sales is at 100, Profit is at 807, Shares in issue is at 684, against 100 in 2022.

Sales is at 100, Profit is at 807, Shares in issue is at 684, against 100 in 2022.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales, where the first year is 100100
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Profit, where the first year is 100807
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself
Shares in issue, where the first year is 100684
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-127557
Reported in
USD
The filing itself